CVE-2026-18531

MEDIUMCVSS 5.3/10EPSS 0.38%

Last modified

CVE-2026-18531 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. IBM Maximo Application Suite 9.2, 9.1, and 9.0 could allow a remote attacker to tamper with session data due to the use of a weak HMAC session signing secret.. EPSS estimates a 0.38% chance of exploitation in the next 30 days.

Description

IBM Maximo Application Suite 9.2, 9.1, and 9.0 could allow a remote attacker to tamper with session data due to the use of a weak HMAC session signing secret.

Metrics

CVSS 3.1
5.3/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N

EPSS Probability
0.38%

30.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
IbmMaximo Application Suite>= 9.0, < 9.0.28
IbmMaximo Application Suite>= 9.1, < 9.1.20
IbmMaximo Application Suite9.2

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-18531?
IBM Maximo Application Suite 9.2, 9.1, and 9.0 could allow a remote attacker to tamper with session data due to the use of a weak HMAC session signing secret.
How severe is CVE-2026-18531?
CVE-2026-18531 has a CVSS score of 5.3/10 (MEDIUM severity). The EPSS model estimates a 0.38% probability of exploitation in the next 30 days.
How do I fix CVE-2026-18531?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-18531?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST